[go: up one dir, main page]

AU2001232182A1 - Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols - Google Patents

Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols

Info

Publication number
AU2001232182A1
AU2001232182A1 AU2001232182A AU3218201A AU2001232182A1 AU 2001232182 A1 AU2001232182 A1 AU 2001232182A1 AU 2001232182 A AU2001232182 A AU 2001232182A AU 3218201 A AU3218201 A AU 3218201A AU 2001232182 A1 AU2001232182 A1 AU 2001232182A1
Authority
AU
Australia
Prior art keywords
hypercholesterolmia
limonoids
tocotrienols
lipoproteins
flavonoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232182A
Other languages
English (en)
Inventor
Najla Guthrie
Elzbieta Maria Kurowska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KGK Synergize Inc
Original Assignee
KGK Synergize Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KGK Synergize Inc filed Critical KGK Synergize Inc
Publication of AU2001232182A1 publication Critical patent/AU2001232182A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001232182A 2001-01-15 2001-01-15 Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols Abandoned AU2001232182A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/000256 WO2002055071A1 (fr) 2001-01-15 2001-01-15 Compositions et methodes de regulation du taux de lipoproteines et de l'hypercholesterolemie au moyen de limonoides, de flavonoides et de tocotrienols

Publications (1)

Publication Number Publication Date
AU2001232182A1 true AU2001232182A1 (en) 2002-07-24

Family

ID=11004047

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232182A Abandoned AU2001232182A1 (en) 2001-01-15 2001-01-15 Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols

Country Status (2)

Country Link
AU (1) AU2001232182A1 (fr)
WO (1) WO2002055071A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987125B1 (en) 1998-10-06 2006-01-17 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2002308324B2 (en) * 2001-05-02 2008-04-03 Kgk Synergize Inc. Polymethoxylated flavones for treating insulin resistance
CA2567969A1 (fr) * 2004-05-26 2005-12-08 Kgk Synergize Inc. Compositions contenant des flavonoides et des tocotrienols et methodes associees
ZA200610167B (en) * 2004-05-26 2008-07-30 Kgksynergize Inc Functional foods comprising flavonoids and tocotrienols and methods thereof
WO2006049234A1 (fr) 2004-11-08 2006-05-11 Arkray, Inc. Activateur de récepteurs activés par les proliférateurs de peroxysomes (ppar) et médicament, aliment de complément, aliment fonctionnel et additif alimentaire utilisant celui-ci
US20070117763A1 (en) * 2005-11-10 2007-05-24 Kgk Synergize Inc. Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols
ATE510538T1 (de) 2006-08-11 2011-06-15 Univ Johns Hopkins Zusammensetzungen und verfahren für nervenschutz
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
KR100213895B1 (ko) * 1996-10-14 1999-08-02 박원훈 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
CA2307553C (fr) * 1997-10-28 2003-06-17 Korea Institute Of Science And Technology Extrait d'ecorce d'agrumes en tant qu'inhibiteur d'acyle coa-cholesterol-o-acyltransferase, inhibiteur de l'accumulation du complexe macrophage-lipide sur les parois arterielles et agent de prevention ou de traitement des maladies hepatiques
ID28460A (id) * 1998-07-08 2001-05-24 Lipogenics Inc Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol

Also Published As

Publication number Publication date
WO2002055071A1 (fr) 2002-07-18
WO2002055071A8 (fr) 2002-08-15

Similar Documents

Publication Publication Date Title
IL152918A0 (en) Stabilized tetrazolium-phenazine reagent compositions and methods for using the same
AUPR571301A0 (en) Airborne gravity gradiometers
AU2001232182A1 (en) Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols
AU2002316723A1 (en) Ocular ionthophoretic device and method for using the same
AU2002218919A1 (en) Compositions and methods for regulating receptor clustering
AU2002360565A1 (en) Compositions and methods for normalizing assays
AU2002365035A1 (en) Direct mailing device
AU2002365136A1 (en) Compositions and methods for controlled release
AU2002329406A1 (en) An osteoprosthesis component
AUPR810901A0 (en) Measurment device
AU2002303560A1 (en) Integrated control center environment
AU2001295689A1 (en) Compositions and methods for regulating the nervous system
AU2002250888A1 (en) Device for affecting rooms or components thereof
AU2002317637A1 (en) Balancing device
AU2002357489A1 (en) Damping arrangement
AU2002340606A1 (en) Carrying or guiding device for aircraft components
AU2002364874B2 (en) Method and device for evaluating the skeleton balance forces
AU2002351554A1 (en) Transient damping arrangement
AU2002342181A1 (en) Suspension device
AU2002232351A1 (en) Setting device for sawblades
AU2002315672A1 (en) Electromagnetic regulating device
AU2002349304A1 (en) Electromagnetic regulating device
AU2002349322A1 (en) Ventilation device
AU2002313104A1 (en) Ventilation device
AU2002309257A1 (en) Protective structure for articulations and method for making the same